for their contribution to the scientific programme for ......ifmad 2019 | final programme 4 posters...

IFMAD 2019 | Final Programme 1

Dear Colleagues, dear Friends, We are delighted to invite you to the 18th International Forum on Mood and Anxiety Disorders that will be held in July in Vienna. IFMAD has a long and successful tradition of inviting international expert speakers on subjects which provide new insights in treatment of various psychiatric disorders. The meeting always takes place in a collegiate setting which allows for an open interaction between speakers, other experts present and the registrants both in the meeting room and in the intervals. This year we expect a lively discussion on treatment resistant depression with new findings on rapid response within a day in TRD. The latest findings on the genetic basis of TRD will open the way to the use of personalized treatment of depression to reduce the chance of resistance developing. There will be overviews of the contribution of inflammation to mood and anxiety disorders and also the link between nutrition and psychiatry. Updates on new antipsychotics in schizophrenia and on the treatment of negative and depressive symptoms in schizophrenia will be presented. New studies on bipolar disorders have helped clarify the issues of treatment of bipolar depression and the associated cognitive impairment. An update on the risks of valproate will question its widespread use. A major current concern, which will be addressed in the meeting, is the apparent overuse of valproate in women of child bearing age. There will be sessions on anxiety disorders and a focus on long-term treatment and on comorbidity with alcohol dependence. We look forward to updates on the application of digital technology in psychiatry and the need for and use of rapid treatments for suicidality. We look forward to seeing you all in Vienna for IFMAD 2019, to building strong professional contacts an expanding international network, to welcoming new participants and meeting our old friends, and discussing together the most important issues in this area of medicine! A warm welcome from IFMAD chairmen! Siegfried Kasper Stuart Montgomery Eduard Vieta Allan Young

WELCOME


ommittee expresses their gratitude

For their contribution in supporting the poster presenters

For their contribution to the Scientific Programme

For their contribution to the Congress

D. Baldwin (United Kingdom), B. Bandelow (Germany), M. Bauer (Germany), T. Dinan (Ireland), E. Eriksson

(Sweden), N. Fineberg (United Kingdom), S. Kennedy (Canada), D. Lecic Tosevski (Serbia), A.A. Mathé

(Sweden), H.J. Möller (Germany), S. Pallanti (Italy), J. Raboch (Czech Republic), Z. Rihmer (Hungary), A. Serretti

(Italy), D.J. Stein (South Africa), T. Svensson (Sweden), D. Winkler (Austria), S. Yamawaki (Japan), J. Zohar

(Israel)

ACKNOWLEDGEMENTS

SCIENTIFIC ADVISERS


15h00 – 18h20 SCIENTIFIC SESSION – Chairs: S. KASPER – E. VIETA

15h00 - 15h40 SE. 01 Personalised treatment of TRD in practice Alexander Kautzky (Austria)

15h40 - 16h20 SE. 02 Nutritional psychiatry: focus on mood disorders Timothy Dinan (Ireland)

16h20 - 17h00 SE. 03 Treating cognitive dysfunction in mood disorders Eduard Vieta (Spain)

17h00 - 17h40 SE. 04 Advances in technology and digital psychiatry Diego Hidalgo-Mazzei (Spain)

17h40 - 18h20 On-line Survey Stuart Montgomery (United Kingdom)

18h30 OPENING RECEPTION

09h00 – 11h00 SCIENTIFIC SESSION – Chairs: T. DINAN - N. FINEBERG

09h00 - 09h40 SE. 05 Recent regulatory guidance about certain mood-stabilising medicines in women of child-bearing potential: are some prescriptions worth the risk? David Baldwin (United Kingdom)

09h40 - 10h20 SE. 06 Therapeutic implications of including hypochondriasis in the ICD-11 Obsessive-Compulsive or Related Disorders (OCRDs) Naomi Fineberg (United Kingdom)

10h20 - 11h00 SE. 07 Enduring effect of psychotherapy vs medication in anxiety disorders Borwin Bandelow (Germany)

11h00 - 11h30 COFFEE BREAK

11h30 - 12h30 SPONSORED SESSION

12h30 - 13h30 LUNCH

SCIENTIFIC PROGRAMME - Thursday, 04 July 2019

SCIENTIFIC PROGRAMME - Friday, 05 July 2019


POSTERS

13h30 – 15h30 SCIENTIFIC SESSION – Chairs: B. BANDELOW - A. YOUNG

13h30 - 14h10 SE. 08 New findings on lithium Markus Dold (Austria)

14h10 - 14h50 SE. 09 Can we restore altered biological pathways in TRD starting from genetic findings? Chiara Fabbri (Italy)

14h50 - 15h30 SE. 10 Treatment of depressive and negative symptoms of schizophrenia Istvan Bitter (Hungary)

15h30 - 16h00 COFFEE BREAK

16h00 – 18h00 SCIENTIFIC SESSION – Chairs: A. SERRETTI - A. YOUNG

16h00 - 16h40 SE. 11 The role of anxiety in Baclofen treatment for alcohol dependence Julia Sinclair (United Kingdom)

16h40 - 17h20 SE. 12 Rapid Acting treatment in depression Siegfried Kasper (Austria)

17h20 - 18h00 SE. 13 Psychopharmacological approaches to Bipolar Depression Allan Young (United Kingdom)

18h00 - 18h30 KEYNOTE LECTURE – Chair: I. BITTER

18h00 - 18h30 Transcranial magnetic stimulation Stefano Pallanti (Italy)

08h30 - 09h30 STROLLING POSTER SESSION AND COFFEE BREAK

Chairs: S. MONTGOMERY - S. KASPER - A. YOUNG – S. PALLANTI

09h30 – 11h20 SCIENTIFIC SESSION – Chairs: C. FABBRI - S. MONTGOMERY

09h30 - 10h10 SE. 14 New antipsychotics in the treatment of depression Alessandro Serretti (Italy)

10h10 - 10h40 SE. 15 Inflammation in Affective Disorders Allan Young (United Kingdom)

10h40 - 11h20 SE. 16 Genetic testing in psychiatry : what clinicians need to know Chiara Fabbri (Italy)

11h20 - 12h15 CLOSING REMARKS - POSTER AWARDS AND FAREWELL COFFEE

SCIENTIFIC PROGRAMME - Saturday, 06 July 2019


POSTERS

Industry Sponsored Lecture – Friday, 05 July 2019

DISCLAIMER: THE FOLLOWING LECTURE IS ORGANISED BY INDUSTRY. YOU CANNOT CLAIM CME CREDITS FOR ATTENDING THIS SESSION 11h30 - 12h30 SPONSORED SESSION

‘How to manage patients with treatment resistant depression: could it also be ADHD?’ Toni Ramos (Spain) This lecture is organised and funded by Shire, now part of Takeda (and is intended for Healthcare Professionals only).

Imperial Riding School Renaissance Vienna Hotel


POSTERS

Equipment for computerized Power Point presentation is provided during the scientific sessions. Power Point presentations, CD-Rom or USB keys can be viewed and tested prior to presentation at the Speakers’ Corner and must be handed over to the room technicians at least forty minutes before the beginning of the sessions and collected directly by the speakers immediately after. It is essential for the smooth running of the sessions that all Speakers hand in their presentation in due time.

The IFMAD Workshop has been accredited by the European Accreditation Council for Continuing Medical

Education (EACCME®) with 10 European CME credits (ECMEC®s). To obtain your certificate please log I with

your personal log-in credentials sent by mail on the website http://ifmad.org/, and complete the questionnaire.

Credits’certificates will be available from July 12th, 2019 to July 20th, 2019. After this date they will not be available

anymore.

The certificate of attendance will be downloadable from the website www.ifmad.org using your personal

credentials sent by e-mail, starting from July 12th, 2019.

The participant’s name badge are provided at the registration desk. All participants are requested to wear the

badge throughout the congress. Only badge holders are admitted to the appropriate sessions and Opening

Reception.

The official language of the Congress is English. No simultaneous translation is provided.

The Congress organizers cannot accept liability for personal injuries sustained, or for loss or damage to.

The secretariat desk opens on Thursday, 04 July 2019 and stays open all through the Congress.

All delegates are cordially invited to attend the Opening Reception which is held on Thursday, 04 July at 18.30

at the Imperial Riding School Hotel.

GOOD TO KNOW

^

AUDIO - VISUAL

EUROPEAN ACCREDITATION

CERTIFICATE OF ATTENDANCE

ADMISSION

LANGUAGE

WELCOME COCKTAIL

GENERAL INFORMATION

SECRETARIAT

http://ifmad.org/

http://www.ifmad.org/


POSTERS

P.01 The basis of Ketamine action and its role on the treatment of Major Depressive Disorder

Hugo Afonso; Vera Froes1; Ivan Varela1; Sergio Esteves1; Miguel Carneiro1; Glaucia Lima1

1Centro Hospitalar of Barreiro Montijo, Barreiro, Portugal

P.02 Practice of maintenance electroconvulsive therapy

Jakub Albrecht1; Tadeas Mares1; Jozef Buday1; Gabriela Podgorna1; Jiri Raboch1; Martin Anders1

1Department of Psychiatry First Faculty of Medicine Charles University and General University Hospital, Prague,

Czech Republic

P.03 The Impact of Suicidality on Major Depressive Disorder - Results from the European Group for the Study

of Resistant Depression

Lucie Bartova1; Markus Dold1; Gernot Fugger1; Alexander Kautzky1; Daniel Souery2,3; Julien Mendlewicz2; George N. Papadimitriou4; Dimitris Dikeos4; Panagiotis Ferentinos5; Stefano Porcelli6; Alessandro Serretti6; Joseph Zohar7; Stuart Montgomery8; Siegfried Kasper1

1Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; 2School of Medicine, Free University of Brussels, Brussels, Belgium; 3Psy Pluriel - European Centre of Psychological Medicine, Brussels, Belgium; 4First Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, Athens, Greece; 5Second Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, Attikon General Hospital, Athens, Greece; 6Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy; 7Psychiatric Division, Chaim Sheba Medical Center, Tel Hashomer, Israel; 8Imperial College, University of London, London, United Kingdom

P.04 Spadin and shortened spadin analogs as efficient new antidepressants in mouse models of post-stroke

depression

Marc Borsotto1; Mariel Pietri1; Alaeddine Djillani1; Jean Mazella1; Catherine Heurteaux1

1Centre National de la Recherche Scientifique, Institut De Pharmacologie Moléculaire et Cellulaire, UMR7275,

Valbonne, France

P.05 Comparison of depression, anxiety, and suicide ideation in transgender individuals based on their parents’

reaction

Jinhyuk Choi1

1Bongseng memorial hospital, Busan, South Korea

P.06 Bipolar Disorder – Is gender important?

Ana Beatriz Cordeiro de Medeiros1; Cátia Fernandes Santos1; Magda Veiga Pereira1

1Serviço de Psiquiatria e Saúde Mental do Hospital Garcia de Orta, Almada, Portugal

POSTERS


POSTERS

P.07 Seasonal variation of benzodiazepine utilization among the Croatian population

Marija Delaš Aždajić1,3; Stjepan Aždajić1; Robert Likić2,3; Danijela Štimac Grbić3,4

1Sestre Milosrdnice University Hospital Center, Zagreb, Croatia; 2University Hospital Centre Zagreb, Zagreb,

Croatia; 3School of Medicine, University of Zagreb, Zagreb, Croatia; 4Croatian Institute of Public Health, Zagreb,

Croatia

P.08 Pharmacological management of acute mania: a 2-year retrospective study of prescription patterns in a

portuguese acute psychiatric unit

Cátia Fernandes Santos1; Ana Beatriz Medeiros1; Filipa Senos Moutinho1

1Department of Psychiatry and Mental Health, Hospital Garcia de Orta, Almada, Portugal

P.09 Cyberchondria as an emerging trans-diagnostic digital compulsive syndrome: An updated systematic

review and clinical case report

Matteo Vismara1,2; Eduardo Cinosi1,3; Bernardo Dell’Osso2; Giovanni Martinotti3,4; Naomi A Fineberg1,3

11 Hertfordshire Partnership University NHS Foundation Trust, Rosanne House, Welwyn Garden City,

Hertfordshire, United Kingdom; 2University of Milan, Department of Mental Health, Department of Biomedical

and Clinical Sciences Luigi Sacco, Milan, Italy; 3University of Hertfordshire, Hatfield, United Kingdom; 4University

G.d’Annunzio University, Department of Neuroscience, Imaging, Clinical Sciences,, Chieti-Pescara, Italy

P.10 The study of the clinical and psychological characteristics of patients with anxious neurotic disorders in

the course of analytical-cathartic therapy.

Evgenii Ilchenko1

1St. Petersburg "Hospital named after P.P. Kashchenko", Saint Petersburg, Russian Federation

P.11 Pain behavior: new application of dire scale in patients with chronic pain syndromes

Olena Khaustova1

1Bogomolets National Medical University, Kyiv, Ukraine

P.12 Oriental herbal medicine for insomnia in elderly with hypertension: a systematic review and meta-

analysis

SangHo Kim1

1Department of Neuropsychiatry of Korean Medicine, Pohang Korean Medicine Hospital Affiliated to Daegu

Haany University, Pohang, South Korea

P.13 Rapid augmentation of antipsychotic drugs by sodium nitroprusside (SNP). Behavioral assessment and

effect on brain dopaminergic transmission in rats

Joep Titulaer1,2; Anna Malmerfelt2; Monica Marcus2; Åsa Konradsson Geuken1,2; Alessia Perrone3; Giesbert

Alken3; John Lowry4; Torgny Svensson2

1Uppsala University, Uppsala, Sweden; 2Karolinska Institutet, Stockholm, Sweden; 3BDD Drug Development

GmbH, Berlin, Germany; 4National University of Ireland Maynooth, Maynooth, Ireland


POSTERS

P.14 Association between cognitive functions and suicidal ideation in patients with mood disorder

Suyeon Lee1; Woojae Myung1; Kichang Kim1; Sunghee Oh1; Nayoung Cho1; Yun seong Park1; Taewon Chung1;

Hyun A Ryoo1; Tae Hyon Ha1

1Department of Psychiatry, Seoul National University Bundang Hospital, Seongnam, South Korea

P.15 Personalized psychotherapy system for depressive disorders, taking into account the prognosis factors of

their course

Natalia Maruta1; Viktoriya Fedchenko1

1"Institute of neurology, psychiatry and narcology of NAMS of Ukraine" SI, Kharkiv, Ukraine

P.16 Peculiarities of anxiety in the structure of mental health disorders of different genesis

Nataliya Maruta1; Tamara Panko1; Iryna Yavdak1; Galina Kalenskaya1; Oksana Maruta1

1"Institute of Neurology, Psychiatry and Narcology of NAMS of Ukraine" SI, Kharkiv, Ukraine

P.17 Menière’s disease – a psychosomatic disorder?

Ana Beatriz Medeiros1; Filipe Correia2; Luís Castelhano2; Pedro Cavilhas2

1Serviço de Psiquiatria e Saúde Mental do Hospital Garcia de Orta, Almada, Portugal; 2Serviço de Neurologia do

Hospital Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal

P.18 Is there abnormal functional connectivity between the cerebellum and the cerebrum networks in un-medicated patients with obsessive-compulsive disorder? Keitaro Murayama1; Tomohiro Nakao1; Tomiyama Hirofumi1; Hasuzawa Suguru1; Tsuruta Sae2; Ohno Aikana2

1Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; 2Department of Clinical Psychology Practice, Graduate School of Human-Environment Studies, Kyushu University,

Fukuoka, Japan

P.19 Exposure to Ambient Fine Particles and Depressive Symptoms in Alzheimer Disease: CREDOS (Clinical

Research Center for Dementia of South Korea) Study

Woojae Myung1; Hyewon Lee1,2; Hyeong-gwon An3

1Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, South Korea; 2Institute

of Health and Environment, Seoul National University, Seoul, South Korea; 3Department of Psychiatry, CHA

Bundang Medical Center, CHA University, Seongnam, South Korea

P.20 Mobile app for the add-on treatment of generalized anxiety disorder and anxiety in mild to moderate

depressive disorder – an assessment of need of patients and health care professionals

Daniel Neto1,2; Carla Spínola3; Ana Ribeiro Moreira3; Teresa Castelo Branco2; Helena Sofia Pinto4; Joaquim Gago2,5

1Casa de Saúde São João de Deus,, Funchal, Portugal; 2Clínica Grow Space, Lisboa, Portugal; 3Centro Hospitalar

Lisboa Ocidental, Lisboa, Portugal; 4Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal; 5Nova

Medical School, Lisboa, Portugal


POSTERS

P.21 The Effects of a Mobile Application using the MBSR technique on symptom relief of outpatients with panic

disorder: A pilot study

Sunyoung Park1; Jungeun You2,3; Jungeun Song1

1Department of Psychiatry, National Health Insurance Service Ilsan Hospital, Goyang, South Korea; 2Department

of Psychology, Seoul National University, Seoul, South Korea; 3MABO, Seoul, South Korea

P.22 Clinical Implication of Agoraphobia in the Patients with Panic Disorder

Jin Shin1; Jun Jeon Hong1

1Department of Psychiatry, Konkuk University Medical Center, Seoul, South Korea

P.23 Understanding the essence of Mood Disorders through the eyes of poetry

Gulbahar Sidhu1

1Doaba Hospital, Jalandhar, India

P.24 Lithium or valproate in Bipolar Disorder? A 3-Year Prospective Cohort Study

Carla Spínola1; Daniel Neto2; Leonor Santana1; Filipe De Oliveira Azevedo1; Joaquim Gago1,3

1Centro Hospitalar Lisboa Ocidental, Lisboa, Portugal; 2Casa de Saúde São João de Deus, Funchal, Portugal; 3Nova

Medical School, Lisboa, Portugal

P.25 Unique Pharmacology and Clinical Evidence Supporting the Antidepressant Therapeutic Potential of

Lumateperone

Joep Titulaer1,2; Robert Davies3; Sophie Dutheil3; Joseph Hendricks3; Lei Zhang3; Lawrence Wennogle3; Andrew

Satlin3; Monica Marcus3; Sharon Mates3; Kim Vanover3; Gretchen Snyder3; Torgny Svensson2

1Uppsala University, Uppsala, Sweden; 2Karolinska Institutet, Stockholm, Sweden; 3Intra Cellular Therapies, New

York, USA


POSTERS

for their contribution to the scientific programme for ......ifmad 2019 | final programme 4 posters...

Documents